Literature DB >> 7102557

Cardiac effects of prolonged and intense exercise training in patients with coronary artery disease.

A A Ehsani, W H Martin, G W Heath, E F Coyle.   

Abstract

The effects of intense and prolonged exercise training on the heart were studied with echocardiography in eight men with coronary artery disease with a mean age (+/- standard error of the mean) of 52 +/- 3 years. Training consisted of endurance exercise 3 times/week at 50 to 60 percent of the measured maximal oxygen uptake for 3 months followed by exercise 4 to 5 days/week at 70 to 80 percent of maximal oxygen uptake for 9 months. Maximal oxygen uptake capacity increased by 42 percent (26 +/- 1 versus 37 +/- 2 ml/kg per min; p less than 0.001). Heart rate at rest and submaximal heart rate and systolic blood pressure at a given work rate were significantly lower after training. Systolic blood pressure at the time of maximal exercise increased (145 +/- 9 before versus 166 +/- 8 mm Hg after training; probability [p] less than 0.01). Left ventricular end-diastolic diameter was increased after 12 months of training (from 47 +/- 1 to 51 +/- 1 mm; p less than 0.01). Left ventricular fractional shortening and mean velocity of circumferential shortening decreased progressively in response to graded isometric handgrip exercise before training but not after training. At comparable levels of blood pressure during static exercise, mean velocity of circumferential shortening was significantly higher after training (0.76 +/- 0.04 versus 0.98 +/- 0.07 diameter/sec, p less than 0.01). No improvement in echocardiographic or exercise variables was observed over a 12 month period in another group of five patients who did not exercise. Thus the data suggest that prolonged and vigorous exercise training in selected patients with coronary artery disease can elicit cardiac adaptations.

Entities:  

Mesh:

Year:  1982        PMID: 7102557     DOI: 10.1016/0002-9149(82)90173-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

Review 1.  Interval training for patients with coronary artery disease: a systematic review.

Authors:  Aimee K Cornish; Suzanne Broadbent; Birinder S Cheema
Journal:  Eur J Appl Physiol       Date:  2010-10-23       Impact factor: 3.078

Review 2.  [High intensity training (HIT) for the improvement of endurance capacity of recreationally active people and in prevention & rehabilitation].

Authors:  Patrick Wahl; Matthias Hägele; Christoph Zinner; Wilhelm Bloch; Joachim Mester
Journal:  Wien Med Wochenschr       Date:  2010-12

3.  Exercise prescription for cardiac patients. Reasons for concern.

Authors:  T Boone
Journal:  Sports Med       Date:  1986 May-Jun       Impact factor: 11.136

4.  Abolition of exercise induced ST depression after exercise training and its recurrence after beta blockade.

Authors:  I C Todd; J B McGuinness; D Ballantyne
Journal:  Br Heart J       Date:  1988-02

Review 5.  Exercise testing and cardiac rehabilitation in patients with coronary artery disease.

Authors:  S Zoneraich
Journal:  Bull N Y Acad Med       Date:  1983-09

Review 6.  Healthy exercise.

Authors:  A Oberman
Journal:  West J Med       Date:  1984-12

Review 7.  Secondary prevention strategies for coronary heart disease.

Authors:  Shepard D Weiner; LeRoy E Rabbani
Journal:  J Thromb Thrombolysis       Date:  2010-01       Impact factor: 2.300

8.  Electrocardiographic findings in male veteran endurance athletes.

Authors:  R J Northcote; G P Canning; D Ballantyne
Journal:  Br Heart J       Date:  1989-02

9.  Influence of physical training on blood pressure, plasma renin, angiotensin and catecholamines in patients with ischaemic heart disease.

Authors:  L Vanhees; R Fagard; P Lijnen; E Moerman; H De Geest; A Amery
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1984

Review 10.  Rehabilitation in cardiac patients:what do we know about training modalities?

Authors:  Dominique Hansen; Paul Dendale; Jan Berger; Romain Meeusen
Journal:  Sports Med       Date:  2005       Impact factor: 11.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.